CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CYTR's Revenue Growth by Quarter and Year

Cytrx's Revenue results by quarter and year




CYTR Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 0.00 0.25 0.10 0.10
III Quarter September - 0.25 - -
II Quarter June - - - 0.10
I Quarter March - - - -
FY   - 0.50 0.10 0.20



CYTR Revenue forth quarter 2019 Y/Y Growth Comment
Cytrx Corp in the forth quarter recorded of $ 0.00 millions.

According to the results reported in the forth quarter, Cytrx Corp achieved the best Revenue growth in Biotechnology & Drugs industry. While Cytrx Corp' s Revenue no change of % ranks overall at the positon no. in the forth quarter.




CYTR Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 150 % 0 % 0 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - 400 % -50 % 100 %

Financial Statements
Cytrx's forth quarter 2019 Revenue $ 0.00 millions CYTR's Income Statement
Cytrx's forth quarter 2018 Revenue $ 0.25 millions Quarterly CYTR's Income Statement
New: More CYTR's historic Revenue Growth >>


CYTR Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 0 % - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - 400 % -50 % 100 %




Revenue forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Cytrx's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYTR's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYTR's IV. Quarter Q/Q Revenue Comment


Cytrx's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Dec 31 2019 period, Cytrx's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Cytrx Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Dec 31 2019 period, Cytrx's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Cytrx Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CYTR's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CYTR's Competitors
Revenue Growth for Cytrx's Suppliers
Revenue Growth for CYTR's Customers

You may also want to know
CYTR's Annual Growth Rates CYTR's Profitability Ratios CYTR's Asset Turnover Ratio CYTR's Dividend Growth
CYTR's Roe CYTR's Valuation Ratios CYTR's Financial Strength Ratios CYTR's Dividend Payout Ratio
CYTR's Roa CYTR's Inventory Turnover Ratio CYTR's Growth Rates CYTR's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2019
Mannkind Corp -0.24 %$ -0.243 millions
Petmed Express Inc -0.25 %$ -0.255 millions
Alpha Pro Tech Ltd -0.46 %$ -0.456 millions
Five Star Senior Living inc -1.13 %$ -1.132 millions
Orasure Technologies Inc -1.15 %$ -1.150 millions
Atrion Corp -1.32 %$ -1.317 millions
Zoetis Inc -1.36 %$ -1.355 millions
Titan Pharmaceuticals Inc -1.54 %$ -1.537 millions
Dynatronics Corp -1.57 %$ -1.574 millions
Phibro Animal Health Corp -1.93 %$ -1.930 millions
Five Prime Therapeutics Inc -2.07 %$ -2.074 millions
Magellan Health inc -2.28 %$ -2.276 millions
Akorn Inc -2.46 %$ -2.458 millions
Heat Biologics Inc -2.87 %$ -2.868 millions
Beigene ltd -3.03 %$ -3.031 millions
Livanova Plc -3.16 %$ -3.163 millions
Ironwood Pharmaceuticals inc -3.36 %$ -3.360 millions
Accuray Incorporated -3.41 %$ -3.413 millions
Arbutus Biopharma Corp -3.58 %$ -3.576 millions
Encision Inc -3.71 %$ -3.709 millions
Vascular Biogenics Ltd -3.93 %$ -3.932 millions
Genesis Healthcare Inc -4.26 %$ -4.259 millions
Hutchison China Meditech Limited -4.31 %$ -4.306 millions
Cytomx Therapeutics Inc -4.45 %$ -4.455 millions
Invacare Corporation -4.77 %$ -4.769 millions
Community Health Systems Inc -4.84 %$ -4.836 millions
Innoviva inc -4.87 %$ -4.867 millions
Heska Corp -5.11 %$ -5.111 millions
Stereotaxis Inc -5.16 %$ -5.164 millions
Jaguar Health Inc -5.57 %$ -5.566 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VERY's Profile

Stock Price

VERY's Financials

Business Description

Fundamentals

Charts & Quotes

VERY's News

Suppliers

VERY's Competitors

Customers & Markets

Economic Indicators

VERY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071